Physician profile
Kendra Kesty
NPI 1568844702
$1,951.80
in general payments reported to CMS, 2019-2025
33 companies · $433 in 2025
The $433 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $136 · 2021: $65.07 · 2022: $408 · 2023: $503 · 2024: $267 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,203.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $368.14 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $162.18 | 2021-2024 | |
| Gynesonics, INC. | $146.00 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $136.32 | 2020-2025 | Veozah |
| Intuitive Surgical, INC. | $128.42 | 2025 | |
| Pfizer INC. | $126.53 | 2019-2025 | |
| Biogen, INC. | $111.35 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $66.68 | 2024-2025 | Myfembree, Gemtesa |
| Takeda Pharmaceuticals U.S.A., INC. | $57.37 | 2022-2025 | Trintellix |
| Shield Therapeutics INC | $48.35 | 2024-2025 | |
| Therapeuticsmd, INC. | $46.85 | 2019-2022 | |
| Hologic Sales and Service, LLC | $41.95 | 2023-2025 | Acessa Provu System, Fetal Fibronectin Enzyme Immunoassay |
| Exeltis, USA INC. | $39.56 | 2019-2025 | Slynd |
| Daiichi Sankyo INC. | $39.47 | 2020-2022 | |
| Cepheid | $38.99 | 2025 | Genexpert |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $38.73 | 2023-2024 | Cologuard Collection Kit |
| Bausch Health US, LLC | $32.16 | 2020-2022 | |
| Applied Medical Resources Corporation | $30.51 | 2023 | |
| Ferring Pharmaceuticals INC. | $30.39 | 2019 | |
| Avion Pharmaceuticals | $29.50 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $28.76 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.69 | 2022 | |
| Mission Pharmacal Company | $20.67 | 2019 | |
| Medtronic, INC. | $19.88 | 2023 | Interstim |
| Organon LLC | $19.46 | 2021-2024 | |
| Myovant Sciences INC. | $18.19 | 2022 | |
| Lupin INC. | $16.97 | 2019 | |
| Evofem Biosciences, INC. | $16.82 | 2023 | Phexxi |
| Lilly USA, LLC | $15.83 | 2025 | Zepbound |
| Coopersurgical, INC. | $15.60 | 2025 | Sos |
| Vertex Pharmaceuticals Incorporated | $14.81 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.68 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Kesty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.